| Metric | Q3 2023 | Q2 2023 | Q3 2022 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $397M | $396M | $398M | 0.3% | -0.3% |
| Op. Income | $64M | $62M | $52M | 3.1% | 22.5% |
| Gross Margin | 30.1% | 32.7% | 28.1% | -2.6pp | 2.0pp |
| Net Margin | 7.3% | 6.7% | 5.7% | 0.7pp | 1.6pp |
| EPS (Diluted) | $1.41 | $1.27 | $1.08 | 11.0% | 30.6% |
| Free Cash Flow | $68M | $18M | $22M | 270.9% | 205.5% |
| Item | Amount |
|---|---|
| REVENUE | $397M |
| Cost of Revenue | $277M |
| GROSS PROFIT | $120M |
| R&D Expenses | $0 |
| Selling & Marketing | $9M |
| General & Administrative | $30M |
| SG&A Expenses | $39M |
| Other Expenses | $17M |
| Operating Expenses | $56M |
| Cost & Expenses | $333M |
| OPERATING INCOME | $64M |
| Interest Income | $539.0K |
| Interest Expense | $19M |
| Other Income/Expenses | -$20M |
| INCOME BEFORE TAX | $43M |
| Income Tax Expense | $14M |
| Net Income from Continuing Ops | $29M |
| Net Income from Discontinued Ops | $0 |
| NET INCOME | $29M |
| BOTTOM LINE NET INCOME | $29M |
| D&A | $14M |
| EBIT | $62M |
| EBITDA | $77M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| REVENUE | $397M |
| Cost of Revenue | $277M |
| GROSS PROFIT | $120M |
| R&D Expenses | $0 |
| Selling & Marketing | $9M |
| General & Administrative | $30M |
| SG&A Expenses | $39M |
| Other Expenses | $17M |
| Operating Expenses | $56M |
| Cost & Expenses | $333M |
| OPERATING INCOME | $64M |
| Interest Income | $539.0K |
| Interest Expense | $19M |
| Other Income/Expenses | -$20M |
| INCOME BEFORE TAX | $43M |
| Income Tax Expense | $14M |
| Net Income from Continuing Ops | $29M |
| Net Income from Discontinued Ops | $0 |
| NET INCOME | $29M |
| BOTTOM LINE NET INCOME | $29M |
| D&A | $14M |
| EBIT | $62M |
| EBITDA | $77M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| Net Income | $29M |
| Depreciation & Amortization | $17M |
| Stock-Based Compensation | $2M |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | -$11M |
| Change in Working Capital | $51M |
| OPERATING CASH FLOW | $88M |
| Capital Expenditure | -$19M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $35M |
| NET CASH FROM INVESTING | $16M |
| Net Debt Issuance | -$8M |
| Common Stock Repurchased | -$28M |
| Common Dividends Paid | -$9M |
| Other Financing Activities | $263.0K |
| NET CASH FROM FINANCING | -$45M |
| FREE CASH FLOW | $68M |
| Net Change in Cash | $59M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $154M |
| Short-Term Investments | $0 |
| Net Receivables | $83M |
| Inventory | $5M |
| Other Current Assets | $44M |
| TOTAL CURRENT ASSETS | $296M |
| PP&E (Net) | $1.8B |
| Goodwill | $339M |
| Intangible Assets | $295M |
| Long-Term Investments | $0 |
| Tax Assets | $0 |
| Other Non-Current Assets | $239M |
| TOTAL NON-CURRENT ASSETS | $2.7B |
| TOTAL ASSETS | $3.0B |
| Account Payables | $51M |
| Short-Term Debt | $30M |
| Deferred Revenue | $14M |
| Other Current Liabilities | $6M |
| TOTAL CURRENT LIABILITIES | $524M |
| Long-Term Debt | $1.7B |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $41M |
| Other Non-Current Liabilities | $140M |
| TOTAL NON-CURRENT LIABILITIES | $3.1B |
| TOTAL LIABILITIES | $3.7B |
| Common Stock | $826.0K |
| Additional Paid-In Capital | $517M |
| Retained Earnings | $1.9B |
| Treasury Stock | -$3.1B |
| Accum. Other Comp. Income | -$53M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | -$705M |
| Minority Interest | $0 |
| TOTAL EQUITY | -$705M |
| TOTAL LIABILITIES & EQUITY | $3.0B |
| Total Debt | $3.1B |
| Net Debt | $3.0B |
